Trinity Press Releases

HEOR, one of the fastest-growing functions in the pharmaceutical industry, provides value-based insight to pharmaceutical companies and assists healthcare payers in determining if treatments are effective in the populations they serve.

New report was developed to guide CCOs in focused launch planning across all areas and at all stages of development, including clinical.

New report was developed to guide CCOs in focused launch planning across all areas and at all stages of development, including clinical.

WALTHAM, Mass. — TRINITY, the global life sciences commercialization solutions provider, today announced it has acquired Bell Canyon Consulting to create a new combined offering that will address critical gaps in the market for improved data management and reporting. With the...

Today TRINITY published a white paper exploring the truth of reimbursement challenges for cell and gene therapies (CGTs).  In recent years, we have seen cell and gene therapies (CGTs) morph from a small niche into one of the most exciting markets...

The 20-year-old firm provides a range of integrated, evidence-based solutions specifically designed and deployed to solve critical commercialization challenges.

TGaS Advisors, a division of Trinity, is launching a Medical Affairs practice to provide life sciences companies with benchmarking, advisory and membership services designed to support evidence-based decision-making in this critical area.

The TGaS® Advisors 2019 Spring Summit was one of the benchmarking and advisory services firm’s largest turnouts.

Boston, April 12, 2019 – Leading global life sciences advisory company Trinity announced expansion of its leadership team with the promotions of: Leslie Orne to Chief Client Officer Herman Sanchez to Senior Partner, Strategic Advisory Neal Dunn to Senior Partner, Insights...

Eleven companies achieved the highest honors in TGaS®Advisors' second annual search for the biopharmaceutical industry's Best of Benchmark.

Tracy L. Mills was promoted to vice president, Executive Commercial Operations (ECOS) practice, for TGaS Advisors.

Trinity, a leading global life sciences consulting firm, today announced it will be a Program Partner for the “Gene Therapy For Rare Disorders” conference taking place on March 26-28 in Boston. Trinity’s Krista Perry will be presenting at the conference to...